This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Khan, A. Articles by Hill, N. Search for Related Content PubMed PubMed Citation Articles by Khan, A. Articles by Hill, N.

Atopic Hypersensitivity to cis-Dichlorodiammineplatinum(II) and Other Platinum Complexes¹

Department of lmmunotherapy [A. K.] and Granville C. Morton Cancer and Research Hospital [W. G., J. M. H., E. L., A. M., N. H.], Wadley Institutes of Molecular Medicine, Dallas, Texas 75235

² To whom requests for reprints should be addressed.

Allergic reaction to an antitumor agent, cis-dichlorodiammineplatinum(II) (DDP) was investigated. A 15-year-old white male with pulmonary metastases from embryonal carcinoma of testis was treated with a combination of DDP, bleomycin, and vinblastine. The dose of DDP varied from 2 to 2.25 mg/kg given i.v. He received 7 doses of DDP in 9 months. An anaphylactic reaction was seen within 3 min of the initiation of i.v. infusion of the 8th dose of DDP. The reaction was due to atopic hypersensitivity, as confirmed by an immediate wheal and flair reaction and increased histamine release from leukocytes with DDP. His serum IgE level was elevated. Neither the presence of chloride nor the amine grouping in DDP was essential for reactivity. The replacement of platinum with palladium abrogated the reactivity. There was no cross-reactivity with 3 other platinum complexes of known antitumor activity (platinum blue, platinum(II) 1,2-diaminocyclohexane malonate, and platinum(II) ethylenediamine malonate). This was also confirmed by the lack of reaction to subsequent i.v. administration of platinum(II) 1,2-diaminocyclohexane malonate (10 mg/kg) in this patient.

¹ Supported by a grant from the Carl B. and Florence E. King Foundation, Dallas, Texas.

Received 5/29/75. Accepted 7/ 9/75.

This article has been cited by other articles:

				D. C. D'Souza, C. H. Katelaris, and P. R. Harnett Hypersensitivity to cisplatin on second rechallenge despite a successful first rechallenge Journal of Oncology Pharmacy Practice, January 1, 1996; 2(2): 117 - 119. [Abstract] [PDF]